Today

Agents

Chat

Arena

Discover

More

App

Aeon Biopharma submits IND for comparative pharmacodynamic study of ABP-450 - AEON News | Rallies

Aeon Biopharma submits IND for comparative pharmacodynamic study of ABP-450

AEON•2026-11-09

Aeon Biopharma submitted an investigational new drug application for a comparative pharmacodynamic study of ABP-450.

1. IND submission

Aeon Biopharma submitted an investigational new drug application for a comparative pharmacodynamic study of ABP-450.

Related News

LifeMD delays Q3 2026 10-Q filing to correct revenue and expense recognition errors

LFMD•2026-11-09

Salvatore Abbate to assume role of LKQ president and CEO on November 9, 2026

LKQ•2026-11-09

Celcuity announces FDA acceptance of sNDA for Revtorpyk in breast cancer

CELC

•

2026-11-09

Global Payments expands adaptive authentication platform with Visa IDX API in US and Canada

GPN•2026-11-09

Performance Shipping announces $4 million share buyback plan

PSHG•2026-11-09